Achieving IPO readiness goes beyond executing on the IPO transaction itself. In this guest commentary Nithya B. Das of ...

Meesho is now aiming to file the draft IPO papers in the second half of 2025 and a potential listing in 2026, contingent on ...

MUSCAT: BankDhofar has achieved a significant milestone with its skillful execution of a successfully subscribed Initial ...

In 2024, global and US markets saw a slight increase in IPOs. Syntax Data used its FIS classification system to analyze the ...

Stock market investors can check Kabra Jewels IPO’s share allotment status online through the NSE website and also on the ...

After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

This shift, as reflected in the Orios report, has led to the creation of 127 unicorns to date, with a combined market ...

The tepid reception to Venture Global's ambitious valuation target shows companies need to set realistic expectations when ...

The startups are the fourth and fifth drugmakers to file for initial stock sales since late December — the most IPO activity ...

Beta Bionics’ public listing comes at a time of potential resurgence in the medtech IPO sector. Last year, medtech offerings were few and far between, though there were still successful IPOs.